|
Volumn 365, Issue 9470, 2005, Pages 1538-1539
|
Increased risk of cardiovascular events with coxibs and NSAIDs.
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
LACTONE;
PROSTAGLANDIN SYNTHASE INHIBITOR;
ROFECOXIB;
SULFONE;
CARDIOVASCULAR DISEASE;
CHEMICALLY INDUCED DISORDER;
CLINICAL TRIAL;
ETHICS;
HUMAN;
INTERPERSONAL COMMUNICATION;
MALE;
NOTE;
PROFESSIONAL STANDARD;
PROSTATE TUMOR;
CARDIOVASCULAR DISEASES;
CLINICAL TRIALS;
CYCLOOXYGENASE INHIBITORS;
DISCLOSURE;
ETHICS COMMITTEES, CLINICAL;
HUMANS;
LACTONES;
MALE;
PROSTATIC NEOPLASMS;
SULFONES;
MLCS;
MLOWN;
|
EID: 18744382787
PISSN: None
EISSN: 1474547X
Source Type: Journal
DOI: 10.1016/S0140-6736(05)66448-3 Document Type: Letter |
Times cited : (4)
|
References (0)
|